Literature DB >> 86721

Cimetidine and gastric cancer.

J B Elder, P C Ganguli, I E Gillespie.   

Abstract

Three patients with dyspeptic symptoms who were being treated with the H2-receptor blocking drug, cimetidine, were later found to have gastric carcinoma. It was not possible to determine whether the association was fortuitous, whether the drug had masked the neoplastic change, or whether it was involved in some other way. Repeated clinical and endoscopic evaluation is essential in patients on this treatment for any length of time.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 86721     DOI: 10.1016/s0140-6736(79)92757-0

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  20 in total

1.  Gastric acid suppression and risk of oesophageal and gastric adenocarcinoma: a nested case control study in the UK.

Authors:  L A García Rodríguez; J Lagergren; M Lindblad
Journal:  Gut       Date:  2006-06-19       Impact factor: 23.059

Review 2.  Assessing the safety of drugs for the long-term treatment of peptic ulcers.

Authors:  K G Wormsley
Journal:  Gut       Date:  1984-12       Impact factor: 23.059

Review 3.  H2-receptor antagonists and gastric cancer.

Authors:  J Penston; K G Wormsley
Journal:  Med Toxicol       Date:  1986 May-Jun

Review 4.  Inhibition of acid and gastric carcinoids.

Authors:  J B Elder
Journal:  Gut       Date:  1985-12       Impact factor: 23.059

5.  Antisecretory drugs and gastric cancer.

Authors:  M J Langman
Journal:  Br Med J (Clin Res Ed)       Date:  1985-06-22

6.  Does cimetidine cause gastric cancer?

Authors: 
Journal:  Br Med J (Clin Res Ed)       Date:  1981-04-11

7.  Adverse effects of anti-ulcer drugs.

Authors:  D A Henry; M J Langman
Journal:  Drugs       Date:  1981-06       Impact factor: 9.546

8.  Use of cimetidine and other peptic ulcer drugs in Denmark 1977-1990 with analysis of the risk of gastric cancer among cimetidine users.

Authors:  H Møller; A Nissen; J Mosbech
Journal:  Gut       Date:  1992-09       Impact factor: 23.059

9.  Gastrointestinal lymphoma and sarcoma. A case for aggressive search and destroy.

Authors:  R B Adkins; H W Scott; J L Sawyers
Journal:  Ann Surg       Date:  1987-06       Impact factor: 12.969

10.  Gastric cancer following highly selective vagotomy.

Authors:  P W Houghton; D J Leaper
Journal:  Postgrad Med J       Date:  1987-01       Impact factor: 2.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.